TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 11 | 10 | -4 | -9 | -24 | -7 | -4 |
| S | %wins | 0 | 0 | 100 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/11/05 17:30 | 2/10/05 | CPHD | Cepheid | CA | Electr | LabEq | Laboratory Analytical Instrum | Marks IRA | CA | O | VP,World | M.d | 27 | 5.35 | 2 | 5 | 2 | D | 136 | -16 | 39 | 2 | -4 | 8 | -6 | -4 | 11 | 10 | -4 | -9 | -24 | -7 | |
2/11/05 17:30 | 2/10/05 | CPHD | Cepheid | CA | Electr | LabEq | Laboratory Analytical Instrum | Marks IRA | CA | O | VP,World | S.d | -49 | 9.85 | 2 | -5 | -77 | 2 | D | 136 | -16 | 39 | 2 | -4 | 8 | -6 | -4 | 11 | 10 | -4 | -9 | -24 | -7 |
8/6/03 20:24 | 8/5/03 | NGEN | Nanogen Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Marks IRA | O | VP Busin | M.d | 33 | 1.90 | 0 | 17 | 0 | D | ||||||||||||||||
8/6/03 20:24 | 8/5/03 | NGEN | Nanogen Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Marks IRA | O | VP Busin | S.d | -52 | 3.03 | 0 | -17 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |